Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001339970-25-000013
Filing Date
2025-08-07
Accepted
2025-08-07 16:25:45
Documents
16
Effectiveness Date
2025-08-07

Document Format Files

Seq Description Document Type Size
1 S-8 atyr-20250807.htm S-8 145489
2 EX-5.1 atyr-ex5_1.htm EX-5.1 15549
3 EX-23.2 atyr-ex23_2.htm EX-23.2 3953
4 EX-FILING FEES atyr_exfilingfees.htm   iXBRL EX-FILING FEES 41790
5 GRAPHIC img54294278_0.jpg GRAPHIC 27788
6 GRAPHIC gfx54294278_0.gif GRAPHIC 724
  Complete submission text file 0001339970-25-000013.txt   389473

Data Files

Seq Description Document Type Size
18 EXTRACTED XBRL INSTANCE DOCUMENT atyr_exfilingfees_htm.xml XML 15083
Mailing Address 10240 SORRENTO VALLEY ROAD SUITE 300 SAN DIEGO CA 92121
Business Address 10240 SORRENTO VALLEY ROAD SUITE 300 SAN DIEGO CA 92121 8587318389
aTYR PHARMA INC (Filer) CIK: 0001339970 (see all company filings)

EIN.: 203435077 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-289364 | Film No.: 251194522
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)